In the case of the VAV1 mRNA, we found a significant downmodulation in a small subgroup of samples derived from patients affected by diffuse large B–cell lymphoma (Figure 6A, Table 2), chronic lymphocytic leukemia (Table 2), and acute myeloid leukemia (Table 2). The gene discussed is VAV1; the disease is diffuse large B-cell lymphoma.